George Maronitis

George Maronitis is a skilled research associate at Procella Therapeutics AB since March 2022, with a strong background in neurochemistry and molecular neurobiology from Stockholm University. Previous experience includes a summer internship at the Division of Neurogeriatrics, Karolinska Institutet, focusing on cell line maintenance and monoclonal antibody validation, as well as a master thesis at Uppsala University where George developed a transfection strategy for neuronal progenitor cells using CRISPR/Cas9. Additional roles span various positions in research and service sectors, encompassing laboratory techniques in molecular biology and experience in event management within hospitality. Educational qualifications encompass master's degrees in both Neurochemistry and Molecular Medicine, along with a bachelor's degree in Biochemistry and Biotechnology.